A detailed history of Raymond James Trust N.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Raymond James Trust N.A. holds 10,434 shares of TEVA stock, worth $236,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,434
Previous 10,827 3.63%
Holding current value
$236,017
Previous $175,000 7.43%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.81 - $18.96 $6,213 - $7,451
-393 Reduced 3.63%
10,434 $188,000
Q2 2024

Jul 25, 2024

BUY
$12.78 - $17.4 $536 - $730
42 Added 0.39%
10,827 $175,000
Q1 2024

Apr 24, 2024

BUY
$10.67 - $14.43 $115,075 - $155,627
10,785 New
10,785 $152,000
Q1 2023

May 03, 2023

BUY
$8.36 - $11.37 $4,464 - $6,071
534 Added 4.16%
13,377 $118,000
Q3 2022

Oct 31, 2022

SELL
$6.86 - $11.95 $107,016 - $186,420
-15,600 Reduced 54.85%
12,843 $104,000
Q2 2022

Jul 14, 2022

SELL
$7.38 - $10.4 $11,261 - $15,870
-1,526 Reduced 5.09%
28,443 $214,000
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $32,493 - $41,625
-4,433 Reduced 12.89%
29,969 $281,000
Q4 2021

Jan 31, 2022

SELL
$7.9 - $10.19 $87,618 - $113,017
-11,091 Reduced 24.38%
34,402 $276,000
Q2 2021

Jul 20, 2021

SELL
$9.9 - $11.56 $42,570 - $49,708
-4,300 Reduced 8.64%
45,493 $450,000
Q1 2021

May 03, 2021

BUY
$10.34 - $12.81 $25,653 - $31,781
2,481 Added 5.24%
49,793 $575,000
Q4 2020

Jan 13, 2021

SELL
$8.61 - $11.04 $17,435 - $22,356
-2,025 Reduced 4.1%
47,312 $457,000
Q2 2020

Jul 16, 2020

BUY
$8.12 - $13.12 $64,147 - $103,648
7,900 Added 19.07%
49,337 $608,000
Q1 2020

Apr 17, 2020

BUY
$6.69 - $13.45 $43,110 - $86,671
6,444 Added 18.42%
41,437 $372,000
Q4 2019

Jan 14, 2020

SELL
$6.53 - $10.72 $5,210 - $8,554
-798 Reduced 2.23%
34,993 $343,000
Q3 2019

Oct 24, 2019

BUY
$6.16 - $9.6 $3,080 - $4,800
500 Added 1.42%
35,791 $246,000
Q2 2019

Jul 15, 2019

BUY
$8.12 - $15.72 $18,099 - $35,039
2,229 Added 6.74%
35,291 $326,000
Q1 2019

Apr 15, 2019

BUY
$15.58 - $20.01 $1,760 - $2,261
113 Added 0.34%
33,062 $519,000
Q4 2018

Jan 29, 2019

BUY
$14.59 - $23.84 $16,545 - $27,034
1,134 Added 3.56%
32,949 $509,000
Q3 2018

Oct 16, 2018

BUY
$21.06 - $25.65 $2,632 - $3,206
125 Added 0.39%
31,815 $685,000
Q2 2018

Jul 11, 2018

BUY
$16.77 - $24.71 $148,246 - $218,436
8,840 Added 38.69%
31,690 $771,000
Q1 2018

Apr 05, 2018

SELL
$16.68 - $22.07 $51,624 - $68,306
-3,095 Reduced 11.93%
22,850 $390,000
Q4 2017

Feb 02, 2018

SELL
$11.23 - $19.1 $75,196 - $127,893
-6,696 Reduced 20.51%
25,945 $492,000
Q3 2017

Oct 24, 2017

BUY
$15.41 - $32.17 $126,007 - $263,054
8,177 Added 33.42%
32,641 $574,000
Q2 2017

Aug 10, 2017

BUY
N/A
24,464
24,464 $813,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.